Literature DB >> 27700179

Epigenetic control of the tumor microenvironment.

David L Marks1, Rachel Lo Olson1,2, Martin E Fernandez-Zapico1.   

Abstract

Stromal cells of the tumor microenvironment have been shown to play important roles in both supporting and limiting cancer growth. The altered phenotype of tumor-associated stromal cells (fibroblasts, immune cells, endothelial cells etc.) is proposed to be mainly due to epigenetic dysregulation of gene expression; however, only limited studies have probed the roles of epigenetic mechanisms in the regulation of stromal cell function. We review recent studies demonstrating how specific epigenetic mechanisms (DNA methylation and histone post-translational modification-based gene expression regulation, and miRNA-mediated translational regulation) drive aspects of stromal cell phenotype, and discuss the implications of these findings for treatment of malignancies. We also summarize the effects of epigenetic mechanism-targeted drugs on stromal cells and discuss the consideration of the microenvironment response in attempts to use these drugs for cancer treatment.

Entities:  

Keywords:  DNA and histone methyltransferases; DNA methylation; cancer-associated fibroblasts; chromatin dynamics; endothelial cells; gene expression; histone deacetylases; histone marks; immune cells; noncoding RNAs

Mesh:

Year:  2016        PMID: 27700179      PMCID: PMC5289035          DOI: 10.2217/epi-2016-0110

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  139 in total

Review 1.  SWI/SNF nucleosome remodellers and cancer.

Authors:  Boris G Wilson; Charles W M Roberts
Journal:  Nat Rev Cancer       Date:  2011-06-09       Impact factor: 60.716

2.  Cancer associated fibroblasts express pro-inflammatory factors in human breast and ovarian tumors.

Authors:  Neta Erez; Sarah Glanz; Yael Raz; Camilla Avivi; Iris Barshack
Journal:  Biochem Biophys Res Commun       Date:  2013-07-02       Impact factor: 3.575

3.  A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture.

Authors:  T Niki; K Rombouts; P De Bleser; K De Smet; V Rogiers; D Schuppan; M Yoshida; G Gabbiani; A Geerts
Journal:  Hepatology       Date:  1999-03       Impact factor: 17.425

4.  Pancreatic cancer derived exosomes regulate the expression of TLR4 in dendritic cells via miR-203.

Authors:  Min Zhou; Jionghuang Chen; Liangjing Zhou; Wenchao Chen; Guoping Ding; Liping Cao
Journal:  Cell Immunol       Date:  2014-09-28       Impact factor: 4.868

5.  Colorectal cancer cell-derived microvesicles containing microRNA-1246 promote angiogenesis by activating Smad 1/5/8 signaling elicited by PML down-regulation in endothelial cells.

Authors:  Nami Yamada; Nonoka Tsujimura; Minami Kumazaki; Haruka Shinohara; Kohei Taniguchi; Yoshihito Nakagawa; Tomoki Naoe; Yukihiro Akao
Journal:  Biochim Biophys Acta       Date:  2014-09-10

Review 6.  Targeting EZH2 in cancer.

Authors:  Kimberly H Kim; Charles W M Roberts
Journal:  Nat Med       Date:  2016-02       Impact factor: 53.440

Review 7.  Epigenetic plasticity: a central regulator of epithelial-to-mesenchymal transition in cancer.

Authors:  Upasana Bedi; Vivek Kumar Mishra; David Wasilewski; Christina Scheel; Steven A Johnsen
Journal:  Oncotarget       Date:  2014-04-30

Review 8.  Desmoplasia and chemoresistance in pancreatic cancer.

Authors:  Marvin Schober; Ralf Jesenofsky; Ralf Faissner; Cornelius Weidenauer; Wolfgang Hagmann; Patrick Michl; Rainer L Heuchel; Stephan L Haas; J-Matthias Löhr
Journal:  Cancers (Basel)       Date:  2014-10-21       Impact factor: 6.639

Review 9.  Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.

Authors:  Fahimeh Falahi; Michel van Kruchten; Nadine Martinet; Geke A P Hospers; Marianne G Rots
Journal:  Breast Cancer Res       Date:  2014-07-29       Impact factor: 6.466

10.  Tumor-secreted miR-214 induces regulatory T cells: a major link between immune evasion and tumor growth.

Authors:  Yuan Yin; Xing Cai; Xi Chen; Hongwei Liang; Yujing Zhang; Jing Li; Zuoyun Wang; Xiulan Chen; Wen Zhang; Seiji Yokoyama; Cheng Wang; Liang Li; Limin Li; Dongxia Hou; Lei Dong; Tao Xu; Takachika Hiroi; Fuquan Yang; Hongbin Ji; Junfeng Zhang; Ke Zen; Chen-Yu Zhang
Journal:  Cell Res       Date:  2014-09-16       Impact factor: 25.617

View more
  25 in total

Review 1.  Targeting the tumour stroma to improve cancer therapy.

Authors:  Kenneth C Valkenburg; Amber E de Groot; Kenneth J Pienta
Journal:  Nat Rev Clin Oncol       Date:  2018-06       Impact factor: 66.675

Review 2.  Histone Deacetylases as New Therapeutic Targets in Triple-negative Breast Cancer: Progress and Promises.

Authors:  Nikolaos Garmpis; Christos Damaskos; Anna Garmpi; Emmanouil Kalampokas; Theodoros Kalampokas; Eleftherios Spartalis; Afrodite Daskalopoulou; Serena Valsami; Michael Kontos; Afroditi Nonni; Konstantinos Kontzoglou; Despina Perrea; Nikolaos Nikiteas; Dimitrios Dimitroulis
Journal:  Cancer Genomics Proteomics       Date:  2017 Sep-Oct       Impact factor: 4.069

Review 3.  Aging and cancer epigenetics: Where do the paths fork?

Authors:  Raúl Fernández Pérez; Juan Ramón Tejedor; Agustín Fernández Fernández; Mario Fernández Fraga
Journal:  Aging Cell       Date:  2022-09-14       Impact factor: 11.005

4.  Dihydropyrazole-Carbohydrazide Derivatives with Dual Activity as Antioxidant and Anti-Proliferative Drugs on Breast Cancer Targeting the HDAC6.

Authors:  Irving Balbuena-Rebolledo; Astrid M Rivera-Antonio; Yudibeth Sixto-López; José Correa-Basurto; Martha C Rosales-Hernández; Jessica Elena Mendieta-Wejebe; Francisco J Martínez-Martínez; Ivonne María Olivares-Corichi; José Rubén García-Sánchez; Juan Alberto Guevara-Salazar; Martiniano Bello; Itzia I Padilla-Martínez
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-31

Review 5.  The evolving landscape of N6-methyladenosine modification in the tumor microenvironment.

Authors:  Yunru Gu; Xi Wu; Jingxin Zhang; Yuan Fang; Yutian Pan; Yongqian Shu; Pei Ma
Journal:  Mol Ther       Date:  2021-04-09       Impact factor: 11.454

Review 6.  Pancreatic Cancer, A Mis-interpreter of the Epigenetic Language.

Authors:  Eriko Iguchi; Stephanie L Safgren; David L Marks; Rachel L Olson; Martin E Fernandez-Zapico
Journal:  Yale J Biol Med       Date:  2016-12-23

Review 7.  Teaming Up for Trouble: Cancer Cells, Transforming Growth Factor-β1 Signaling and the Epigenetic Corruption of Stromal Naïve Fibroblasts.

Authors:  Sergio Lamprecht; Ina Sigal-Batikoff; Shraga Shany; Naim Abu-Freha; Eduard Ling; George J Delinasios; Keren Moyal-Atias; John G Delinasios; Alexander Fich
Journal:  Cancers (Basel)       Date:  2018-02-27       Impact factor: 6.639

Review 8.  Melatonin and Mesenchymal Stem Cells as a Key for Functional Integrity for Liver Cancer Treatment.

Authors:  Ehab Kotb Elmahallawy; Yasser Mohamed; Walied Abdo; Tokuma Yanai
Journal:  Int J Mol Sci       Date:  2020-06-25       Impact factor: 5.923

Review 9.  Ex vivo tumor culture systems for functional drug testing and therapy response prediction.

Authors:  Titia G Meijer; Kishan At Naipal; Agnes Jager; Dik C van Gent
Journal:  Future Sci OA       Date:  2017-03-27

10.  Protein arginine methyltransferase 8 gene enhances the colon cancer stem cell (CSC) function by upregulating the pluripotency transcription factor.

Authors:  Haishan Lin; Bin Wang; Jing Yu; Jing Wang; Qin Li; Bangwei Cao
Journal:  J Cancer       Date:  2018-04-06       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.